Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.
days to go:
Expired
investment:
£752,246
Hiro is an insurance technology company aiming to be a contender in the $6.9 trillion insurance industry. The company claims that conventional home insurance does nothing until the damage is already done. Hiro aims to change this scenario. It gives users access to smart technology to protect their property and rewards them accordingly by giving discounts on their insurance quote. The company has signed partnerships with 30+ leading device manufacturers towards this objective for example, Honeywell Home, Philips, and Lightwave, to name few. Hiro asserts that its platform, mobile apps, feature sets, and designs have been validated through an intensive insider's programme. Hiro is approved by the Financial Conduct Authority (FCA). The company has featured in publications like Forbes, the Guardian and the Evening Standard. Hiro will use the investment to develop Research and Development (R&D), furnish legal and compliance documents, and boost marketing and operations.
days to go:
Expired
investment:
£2,069,251
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
Ticketpass is a ticketing platform that is set to disrupt the traditional ticketing industry with an ethical approach by donating to charity every time a ticket is sold. This 'Tech for Good' company aims to create a fair platform that uses ticketing to create a positive impact, allowing anyone to enhance their events for better social impact at no extra cost. Ticketpass won the Warwick Startup Venture Cup in 2016. It also launched its iOS and Android check-in apps in 2018. In 2019, the official launch of Ticketpass was featured by National Industry Media and Forbes. The company will allocate 56% of the funds to team/tech development, 17% to new hires, 10% to marketing and the remaining 17% to Office & Operations.
days to go:
Expired
investment:
£282,667
AndCo offers an open-source, cost-effective, sustainable solution to co-working by turning hotel lobbies and lavish eateries into co-working spaces all over London. The company has over 90 venues, over 1200 members and over 10 brand partnerships. It has been featured major publications including The Telegraph, Forbes, and The Metro. The funds raised will be used for marketing, development, hiring new teammates and working capital.
days to go:
Expired
investment:
£269,231
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.
days to go:
Expired
investment:
£286,096
Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.
days to go:
Expired
investment:
£532,311
Skin In Motion (SIM) is a first-of-its-kind exercise-friendly beauty range that seeks to promote the positive effects of exercise through healthy and confidence-boosting skincare and makeup products specifically designed to be worn pre, during, and post-exercise. SIM claims that its products are available Direct To Consumer (DTC) via its website and are listed on LookFantastic, Amazon and Oliver Bonas. SIM was awarded the 'Best New Business 2020' award by the Women's Business Club. The brand has reached 3 million potential customers and has an Instagram following of 3,000 to date. The company has also featured in Sunday Times Style Magazine, Hello!, RED Magazine, and Women's Health, to name a few. It will use the investment to grow its team, increase marketing and brand awareness, and accelerate new product developments.
days to go:
Expired
investment:
£166,111
EBar is a ‘Beer as a Service’ entity. It argues that music and sporting events experience long bar queues with millions of people waiting in serpentine lines for their pint. EBar aspires to change this. Its patent-protected EBar machine allows a customer to order, pay and dispense two drinks in less than 30 seconds and in half the time taken by a typical event bar. The machine is supplemented with an integrated 'Point of Sale' (PoS) software, payment solution and data reporting systems. The company has secured over £800,000 of funding from private and public sector sources to date. It also deployed new EBar units at pilot events pre-lockdown and commercially in summer 2020 where it served over 3,500 pints in a socially distanced open-air environment. EBar has patents pending across international territories such as North America, Europe, China, Japan, Korea and Australia. It will use the investment to build more units, grow its team, develop supply chain partnerships, and boost business development.
days to go:
Expired
investment:
£356,377
One Year No Beer (OYNB) is a community support platform that helps people change their relationship with alcohol. It does this by allowing its users to choose a plan from the company's subscription-based models that consist of a 28-day, 90-day, and 365-day challenge to stay away from alcohol. The platform has empowered 70,000+ people in 90 countries through its challenges. Excess alcohol consumption leads to 3 million deaths per year and costs up to £59 billion to the UK economy alone. OYNB aims to resolve this crisis through its platform. For its efforts, the platform has been mentioned in publications such as the BBC, ITV, Metro, and Daily Telegraph. It also has an online presence of 130,000+ Facebook and 50,000+ Instagram followers. The company will use 42% of the investment to hire personnel, 33% for technology and product builds, and 25% as overhead costs.
days to go:
Expired
investment:
£1,757,111
